The Precision Medicine Center combines the strong genetic foundation and research strength of the Institute of Translational Medicine in the direction of cardiovascular and tumors, and utilizes the leading domestic and world-leading genetic testing technologies to focus on cardiovascular and tumor genetic diagnosis, drug sensitivity, and application targets. The center currently has a complete experimental platform and technical system, and the sequencing and analysis of genomes, transcriptomes, and epigenetics have a world-class level.

Main research directions:

1. In terms of cardiovascular precision medicine, the center is mainly dedicated to genetic diagnosis and drug sensitivity testing of hereditary heart disease and rare gene mutation heart disease. In addition, it also develops "three highs" for high blood pressure, high blood lipids, and high cholesterol. Population risk assessment of cardiovascular disease, and prediction of corresponding genetic estimates.

2. In terms of tumor precision medicine, the center mainly conducts accurate tumor typing and targeted drug sensitivity testing for people who have already had tumors, and also conducts cancer risk genetic evaluation.

Director: Qihui Zhou

Tel: 0532-82991791

Email: qihuizhou@qdu.edu.cn/zhouqihui521@163.com